Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.35 - $3.28 $2,196 - $20,582
-6,275 Reduced 0.05%
11,984,842 $4.19 Million
Q1 2023

Apr 28, 2023

BUY
$3.28 - $4.81 $35 Million - $51.3 Million
10,657,631 Added 799.23%
11,991,117 $41.5 Million
Q4 2022

Feb 10, 2023

SELL
$3.65 - $4.82 $48.6 Million - $64.1 Million
-13,305,650 Reduced 90.89%
1,333,486 $5.97 Million
Q3 2022

Nov 14, 2022

SELL
$2.66 - $3.97 $2.34 Million - $3.5 Million
-880,364 Reduced 5.67%
14,639,136 $388 Million
Q4 2021

Feb 10, 2022

SELL
$4.89 - $7.59 $19.6 Million - $30.4 Million
-4,000,000 Reduced 20.49%
15,519,500 $85.5 Million
Q2 2021

Aug 12, 2021

SELL
$3.94 - $6.75 $16.9 Million - $29 Million
-4,300,000 Reduced 18.05%
19,519,500 $129 Million
Q4 2019

Feb 18, 2020

BUY
$2.3 - $4.6 $16.9 Million - $33.8 Million
7,348,242 Added 44.61%
23,819,500 $101 Million
Q3 2019

Nov 12, 2019

BUY
$2.9 - $9.56 $2,900 - $9,560
1,000 Added 0.01%
16,471,258 $47.8 Million
Q2 2019

Aug 12, 2019

SELL
$6.7 - $9.13 $6,700 - $9,130
-1,000 Reduced 0.01%
16,470,258 $145 Million
Q3 2018

Nov 09, 2018

BUY
$7.12 - $12.44 $19.2 Million - $33.6 Million
2,702,702 Added 19.63%
16,471,258 $154 Million
Q2 2018

Aug 13, 2018

BUY
$6.21 - $8.21 $18.6 Million - $24.6 Million
3,000,581 Added 27.87%
13,768,556 $95.3 Million
Q1 2018

May 08, 2018

BUY
$6.26 - $10.12 $25.6 Million - $41.4 Million
4,090,000 Added 61.25%
10,767,975 $69.2 Million
Q4 2017

Feb 09, 2018

BUY
$5.6 - $9.9 $36.8 Million - $65 Million
6,566,843 Added 5909.05%
6,677,975 $61.8 Million
Q3 2017

Nov 14, 2017

BUY
$4.73 - $6.16 $525,654 - $684,573
111,132
111,132 $640,000

Others Institutions Holding VRAY

About ViewRay, Inc.


  • Ticker VRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 181,010,000
  • Market Cap $1.81M
  • Description
  • ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...
More about VRAY
Track This Portfolio

Track Fosun International LTD Portfolio

Follow Fosun International LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fosun International LTD with notifications on news.